Welcome to Crene Biotechnology!

+86-576-88205808

Product :

Carfilzomib (PR-171)

Carfilzomib (PR-171) 868540-17-4
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Carfilzomib (PR-171) Purity:98% min
CAS NO:868540-17-4 Solubility:DMSO : 50 mg/mL (69.45 mM)
Molecular Formula:C40H57N5O7 Package:Packaging according to customer requirements
Molecular Weight:719.91 Storage:Store at -20℃
Quality control
COA
Remarks

Carfilzomib, also known as PR-171, is a tetrapeptide epoxyketone and an epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S proteasome, an enzyme responsible for degrading a large variety of cellular proteins. Inhibition of proteasome-mediated proteolysis results in an accumulation of polyubiquinated proteins, which may lead to cell cycle arrest, induction of apoptosis, and inhibition of tumor growth. Carfilzomib was approved by the FDA for use in patients with relapsed and refractory multiple myeloma on 20 July 2012.

 

 

 

 

COVID-19 inhibitor Related Products:

Dexamethasone; Ritonavir; Telaprevir; Lopinavir; PF-07321332; PF-00835231; Danoprevir; Baricitinib; Nafamostat; Lamivudine; Ivermectin; Azithromycin; Praziquantel; TDZD-8; Aloxistatin; Darunavir; Ledipasvir; Remdesivir; Velpatasvir; Boceprevir; Prulifloxacin

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China